143 related articles for article (PubMed ID: 34875609)
1. STAT3 gain-of-function mutation in an adult patient.
López AL; Niemela J; Stoddard J; Paolini MV; Rosenzweig S; Fernández Romero DS
Medicina (B Aires); 2021; 81(6):1065-1068. PubMed ID: 34875609
[TBL] [Abstract][Full Text] [Related]
2. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
Leiding JW; Vogel TP; Santarlas VGJ; Mhaskar R; Smith MR; Carisey A; Vargas-Hernández A; Silva-Carmona M; Heeg M; Rensing-Ehl A; Neven B; Hadjadj J; Hambleton S; Ronan Leahy T; Meesilpavikai K; Cunningham-Rundles C; Dutmer CM; Sharapova SO; Taskinen M; Chua I; Hague R; Klemann C; Kostyuchenko L; Morio T; Thatayatikom A; Ozen A; Scherbina A; Bauer CS; Flanagan SE; Gambineri E; Giovannini-Chami L; Heimall J; Sullivan KE; Allenspach E; Romberg N; Deane SG; Prince BT; Rose MJ; Bohnsack J; Mousallem T; Jesudas R; Santos Vilela MMD; O'Sullivan M; Pachlopnik Schmid J; Průhová Š; Klocperk A; Rees M; Su H; Bahna S; Baris S; Bartnikas LM; Chang Berger A; Briggs TA; Brothers S; Bundy V; Chan AY; Chandrakasan S; Christiansen M; Cole T; Cook MC; Desai MM; Fischer U; Fulcher DA; Gallo S; Gauthier A; Gennery AR; Gonçalo Marques J; Gottrand F; Grimbacher B; Grunebaum E; Haapaniemi E; Hämäläinen S; Heiskanen K; Heiskanen-Kosma T; Hoffman HM; Gonzalez-Granado LI; Guerrerio AL; Kainulainen L; Kumar A; Lawrence MG; Levin C; Martelius T; Neth O; Olbrich P; Palma A; Patel NC; Pozos T; Preece K; Lugo Reyes SO; Russell MA; Schejter Y; Seroogy C; Sinclair J; Skevofilax E; Suan D; Suez D; Szabolcs P; Velasco H; Warnatz K; Walkovich K; Worth A; ; Seppänen MRJ; Torgerson TR; Sogkas G; Ehl S; Tangye SG; Cooper MA; Milner JD; Forbes Satter LR
J Allergy Clin Immunol; 2023 Apr; 151(4):1081-1095. PubMed ID: 36228738
[TBL] [Abstract][Full Text] [Related]
3. A Novel
Deng M; Li Y; Li Y; Mao X; Ke H; Liang W; Lei X; Lau YL; Mao H
Front Immunol; 2022; 13():866638. PubMed ID: 35677041
[TBL] [Abstract][Full Text] [Related]
4. Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review.
Fabre A; Marchal S; Barlogis V; Mari B; Barbry P; Rohrlich PS; Forbes LR; Vogel TP; Giovannini-Chami L
J Allergy Clin Immunol Pract; 2019; 7(6):1958-1969.e9. PubMed ID: 30825606
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Signal Transducer and Activator of Transcription 3 Gain-of-Function and Spectrin Deficiency: A Life-Threatening Case of Severe Hemolytic Anemia.
Ciullini Mannurita S; Goda R; Schiavo E; Coniglio ML; Azzali A; Fotzi I; Tondo A; Tintori V; Frenos S; Sanvito MC; Vignoli M; Luceri C; Bigagli E; Grassi A; D'Elios MM; Favre C; Gambineri E
Front Immunol; 2020; 11():620046. PubMed ID: 33519826
[No Abstract] [Full Text] [Related]
6. Signal transducer and activator of transcription gain-of-function primary immunodeficiency/immunodysregulation disorders.
Consonni F; Dotta L; Todaro F; Vairo D; Badolato R
Curr Opin Pediatr; 2017 Dec; 29(6):711-717. PubMed ID: 28914637
[TBL] [Abstract][Full Text] [Related]
7. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.
Milner JD; Vogel TP; Forbes L; Ma CA; Stray-Pedersen A; Niemela JE; Lyons JJ; Engelhardt KR; Zhang Y; Topcagic N; Roberson ED; Matthews H; Verbsky JW; Dasu T; Vargas-Hernandez A; Varghese N; McClain KL; Karam LB; Nahmod K; Makedonas G; Mace EM; Sorte HS; Perminow G; Rao VK; O'Connell MP; Price S; Su HC; Butrick M; McElwee J; Hughes JD; Willet J; Swan D; Xu Y; Santibanez-Koref M; Slowik V; Dinwiddie DL; Ciaccio CE; Saunders CJ; Septer S; Kingsmore SF; White AJ; Cant AJ; Hambleton S; Cooper MA
Blood; 2015 Jan; 125(4):591-9. PubMed ID: 25359994
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and immunological analysis of the patient with autoimmunity due to germline STAT3 gain-of-function mutation].
Ding Y; Zhang Y; Wang YP; Zhao HY; Chen XM; Xue XH; Bai XM; An YF; Zhang ZY; Tang XM; Zhao XD
Zhonghua Er Ke Za Zhi; 2017 Jan; 55(1):30-36. PubMed ID: 28072956
[No Abstract] [Full Text] [Related]
9. Novel STAT-3 gain-of-function variant with hypogammaglobulinemia and recurrent infection phenotype.
Erdős M; Tsumura M; Kállai J; Lányi Á; Nyul Z; Balázs G; Okada S; Maródi L
Clin Exp Immunol; 2021 Sep; 205(3):354-362. PubMed ID: 34050927
[TBL] [Abstract][Full Text] [Related]
10. Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype.
Faletti L; Ehl S; Heeg M
Biomed J; 2021 Aug; 44(4):412-421. PubMed ID: 34366294
[TBL] [Abstract][Full Text] [Related]
11. Activating mutations of STAT3: Impact on human growth.
Gutiérrez M
Mol Cell Endocrinol; 2020 Dec; 518():110979. PubMed ID: 32818584
[TBL] [Abstract][Full Text] [Related]
12. Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8/STAT3, KIT/STAT3, and IL-2/CD25/Treg axes.
Marega LF; Sabino JS; Pedroni MV; Teocchi M; Lanaro C; de Albuquerque DM; Dos Santos IP; Costa FF; Dos Santos Vilela MM
Immunol Res; 2021 Oct; 69(5):445-456. PubMed ID: 34390446
[TBL] [Abstract][Full Text] [Related]
13. Severe Early-Onset Combined Immunodeficiency due to Heterozygous Gain-of-Function Mutations in STAT1.
Baris S; Alroqi F; Kiykim A; Karakoc-Aydiner E; Ogulur I; Ozen A; Charbonnier LM; Bakır M; Boztug K; Chatila TA; Barlan IB
J Clin Immunol; 2016 Oct; 36(7):641-8. PubMed ID: 27379765
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3.
Tanita K; Sakura F; Nambu R; Tsumura M; Imanaka Y; Ohnishi H; Kato Z; Pan J; Hoshino A; Suzuki K; Yasutomi M; Umetsu S; Okada C; Takagi M; Imai K; Ohara O; Muise AM; Okada S; Morio T; Kanegane H
J Clin Immunol; 2021 May; 41(4):780-790. PubMed ID: 33501615
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation.
Wang W; Liu L; Hui X; Wang Y; Ying W; Zhou Q; Hou J; Yang M; Sun B; Sun J; Wang X
BMC Immunol; 2021 Mar; 22(1):19. PubMed ID: 33731004
[TBL] [Abstract][Full Text] [Related]
16. A novel gain-of-function STAT3 variant in infantile-onset diabetes associated with multiorgan autoimmunity.
Zhou Q; Chen D; Yu J; Zheng B; Zhou W; Jia Z; Zhang A; Gu W
Mol Genet Genomic Med; 2024 Feb; 12(2):e2407. PubMed ID: 38404237
[TBL] [Abstract][Full Text] [Related]
17. Early-onset, fatal interstitial lung disease in STAT3 gain-of-function patients.
Gothe F; Gehrig J; Rapp CK; Knoflach K; Reu-Hofer S; Länger F; Schramm D; Ley-Zaporozhan J; Ehl S; Schwerk N; Faletti L; Griese M
Pediatr Pulmonol; 2021 Dec; 56(12):3934-3941. PubMed ID: 34549903
[TBL] [Abstract][Full Text] [Related]
18. A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance.
Warshauer JT; Belk JA; Chan AY; Wang J; Gupta AR; Shi Q; Skartsis N; Peng Y; Phipps JD; Acenas D; Smith JA; Tamaki SJ; Tang Q; Gardner JM; Satpathy AT; Anderson MS
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34115115
[TBL] [Abstract][Full Text] [Related]
19. Activating de novo monoallelic variants causing inborn errors of immunity in two unrelated children born of HIV-seroconcordant couples.
Lugo Reyes SO; Solórzano Suárez A; Scheffler Mendoza SC; Xóchihua Díaz L; González Serrano ME; López Herrera G; Medina-Torres EA; Cruz Ugalde CI; Olguín-Calderón D; Berrón Ruiz L; Espinosa-Padilla SE; Yamazaki-Nakashimada MA; Murata C
AIDS; 2022 Dec; 36(15):2121-2128. PubMed ID: 36382434
[TBL] [Abstract][Full Text] [Related]
20. Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity.
Jägle S; Heeg M; Grün S; Rensing-Ehl A; Maccari ME; Klemann C; Jones N; Lehmberg K; Bettoni C; Warnatz K; Grimbacher B; Biebl A; Schauer U; Hague R; Neth O; Mauracher A; Pachlopnik Schmid J; Fabre A; Kostyuchenko L; Führer M; Lorenz MR; Schwarz K; Rohr J; Ehl S
Clin Immunol; 2020 Jan; 210():108316. PubMed ID: 31770611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
